The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Effects of gender in amyotrophic lateral sclerosis
Abstract
Background There is evidence that amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), is more common in men than in women and that gender influences the clinical features of the disease. The causes of this are unknown.Objective This review examines the gender differences that are found in ALS and postulates reasons for these differences.Methods A literature review of PubMed (with no date limits) was performed to find information about gender differences in the incidence, prevalence, and clinical features of ALS, using the search terms ALS or MND and gender or sex, ALS prevalence, and SOD1 mice and gender. Articles were reviewed for information about gender differences, together with other articles that were already known to the authors.Results The incidence and prevalence of ALS are greater in men than in women. This gender difference is seen in large studies that included all ALS patients (sporadic and familial), but is not seen when familial ALS is studied independently. Men predominate in the younger age groups of patients with ALS. Sporadic ALS has different clinical features in men and women, with men having a greater likelihood of onset in the spinal regions, and women tending to have onset in the bulbar region. Gender appears to have no clear effect on survival. In animals with superoxide dismutase 1 (sod1) mutations, sex does affect the clinical course of disease, with earlier onset in males. Possible reasons for the differences in ALS between men and women include different exposures to environmental toxins, different biological responses to exogenous toxins, and possibly underlying differences between the male and female nervous systems and different abilities to repair damage.Conclusions There is a complex interaction between gender and clinical phenotypes in ALS. Understanding the causes of the gender differences could give clues to processes that modify the disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The highest prevalence of CMT disease occurs at ages 50–64, with men having a higher prevalence than women [53,88].”
From Effect of Caffeine Consumption on the Risk for Neurological and Psychiatric Disorders: Sex Differences in Human (2020) · cites this paper as [53]
In the citing paper
“As a result, women with CMT1X have less severe outcomes for almost all parameters of motor nerve conduction studies (MNCS) (compound motor action potential amplitude, delay time on exercise, and conduction rate) compared to men with CMT1X [53].”
From Effect of Caffeine Consumption on the Risk for Neurological and Psychiatric Disorders: Sex Differences in Human (2020) · cites this paper as [53]
Citations
Cites
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
Kabashi, E., Valdmanis, P. N., Dion, P., Spiegelman, D., McConkey, B. J., Velde, C. V., Bouchard, J.-P., Lacomblez, L., Pochigaeva, K., Salachas, F., et al. (2008) · Nature Genetics · doi:10.1038/ng.132 · Cited by 1,544
Wijesekera, L. C., & Leigh, P. N. (2009) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-4-3 · Cited by 1,130
Mackenzie, I. R. A., Bigio, E. H., Ince, P. G., Geser, F., Neumann, M., Cairns, N. J., Kwong, L. K., Forman, M. S., Ravits, J., Stewart, H., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21147 · Cited by 992
Prevalence and patterns of cognitive impairment in sporadic ALS
Ringholz, G. M., Appel, S. H., Bradshaw, M. R., Cooke, N., Mosnik, D. M., & Schulz, P. E. (2005) · Neurology · doi:10.1212/01.wnl.0000172911.39167.b6 · Cited by 843
Gender differences in Parkinson's disease
Haaxma, C. A., Bloem, B. R., Borm, G. F., Oyen, W. J. G., Leenders, K. L., Eshuis, S. A., Booij, J., Dluzen, D. E., & Horstink, M. W. I. M. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.103788 · Cited by 744
Van Deerlin, V. M., Leverenz, J. B., Bekris, L. M., Bird, T. D., Yuan, W., Elman, L. B., Clay, D., Wood, E. M., Chen-Plotkin, A. S., Martinez-Lage, M., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70071-1 · Cited by 723
Haverkamp, L. J., Appel, V., & Appel, S. H. (1995) · Brain · doi:10.1093/brain/118.3.707 · Cited by 697
Cognitive impairment in amyotrophic lateral sclerosis
Phukan, J., Pender, N. P., & Hardiman, O. M. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70265-x · Cited by 635
Prognosis in amyotrophic lateral sclerosis: A population-based study
del Aguila, M. A., Longstreth, W. T., McGuire, V., Koepsell, T. D., & van Belle, G. (2003) · Neurology · doi:10.1212/01.wnl.0000049472.47709.3b · Cited by 469
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 379
Zhang, C., Tan, G., Zhang, Y., Zhong, X., Zhao, Z., Peng, Y., Cheng, Q., Xue, K., Xu, Y., Li, X., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14280 · Cited by 39
Zhu, L., Li, S., Li, X., & Yin, P. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00377-7 · Cited by 41
Fontana, A., Marin, B., Luna, J., Beghi, E., Logroscino, G., Boumédiène, F., Preux, P., Couratier, P., & Copetti, M. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10464-2 · Cited by 36
Michels, S., Kurz, D., Rosenbohm, A., Peter, R. S., Just, S., Bäzner, H., Börtlein, A., Dettmers, C., Gold, H.-J., Kohler, A., et al. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11630-4 · Cited by 35
Li, R., Strykowski, R. K., Meyer, M., Mulcrone, P. L., Krakora, D., & Suzuki, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048581 · Cited by 35
Epidemiological and clinical features of amyotrophic lateral sclerosis in a Tunisian cohort
Kacem, I., Sghaier, I., Bougatef, S., Nasri, A., Gargouri, A., Ajroud‐Driss, S., & Gouider, R. (2019) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2019.1704012 · Cited by 35
Soulard, C., Salsac, C., Mouzat, K., Hilaire, C., Roussel, J., Mezghrani, A., Lumbroso, S., Raoul, C., & Scamps, F. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.001 · Cited by 35
Wright, A. L., Gatta, P. A. D., Le, S., Berning, B. A., Mehta, P. M., Jacobs, K. R., Gul, H., Gil, R. S., Hedl, T. J., Riddell, W. R., et al. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15422 · Cited by 30
Human neural progenitors differentiate into astrocytes and protect motor neurons in aging rats
Das, M. M., Avalos, P., Suezaki, P., Godoy, M. I., Garcia, L., Chang, C. D., Vit, J., Shelley, B., Gowing, G., & Svendsen, C. N. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.03.023 · Cited by 33
Sass, L. R., Khani, M., Romm, J., Daners, M. S., McCain, K., Freeman, T., Carter, G. T., Weeks, D. L., Petersen, B., Aldred, J. L., et al. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0164-3 · Cited by 35
Nucleolar stress in C9orf72 and sporadic ALS spinal motor neurons precedes TDP-43 mislocalization
Arogundade, O. A., Nguyen, S., Leung, R., Wainio, D., Gómez-Rodríguez, M. J., & Ravits, J. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01125-6 · Cited by 35
Martin, L. J., Adams, D. A., Niedzwiecki, M. V., & Wong, M. (2022) · Cells · doi:10.3390/cells11213448 · Cited by 35
Brain-computer interfaces for people with amyotrophic lateral sclerosis
Vaughan, T. M. (2020) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63934-9.00004-4 · Cited by 32
McLeod, V. M., Lau, C. L., Chiam, M. D. F., Rupasinghe, T., Roessner, U., Djouma, E., Boon, W. C., & Turner, B. J. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14657 · Cited by 33
Sex Difference in Spinal Muscular Atrophy Patients – are Males More Vulnerable?
Sun, J., Harrington, M. A., Porter, B., & on behalf of the TREAT-NMD Global Registry Network for SMA (2023) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-230011 · Cited by 31
Exploring the Design Space of AAC Awareness Displays
Sobel, K., Fiannaca, A. J., Campbell, J., Kulkarni, H., Paradiso, A., Cutrell, E., & Morris, M. R. (2017) · CHI Conference on Human Factors in Computing Systems · doi:10.1145/3025453.3025610 · Cited by 36
Molecular Pathology of ALS: What We Currently Know and What Important Information Is Still Missing
Jankovská, N., & Matěj, R. (2021) · Diagnostics · doi:10.3390/diagnostics11081365 · Cited by 36
Gastrostomy tube placement is safe in advanced amyotrophic lateral sclerosis
Korb, M. K., Issa, N. P., Roos, R. P., Sweitzer, B. J., Gottlieb, O., Guralnick, A. S., White, S. R., Semrad, C. E., Soliven, B. C., Baroody, J., et al. (2016) · Neurological Research · doi:10.1080/01616412.2016.1259028 · Cited by 32
Sex biology in amyotrophic lateral sclerosis
Zamani, A., Thomas, E., & Wright, D. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102228 · Cited by 35
Just‐Borràs, L., Hurtado, E., Cilleros‐Mañé, V., Biondi, O., Charbonnier, F., Tomàs, M., García, N., Lanuza, M. A., & Tomàs, J. M. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1550-1 · Cited by 33
Clinical and genetic features of patients with amyotrophic lateral sclerosis in southern China
Chen, W., Xie, Y., Zheng, M., Lin, J., Huang, P., Pei, Z., & Yao, X. (2020) · European Journal of Neurology · doi:10.1111/ene.14213 · Cited by 31
Using gene expression signatures to identify novel treatment strategies in gulf war illness
Craddock, T. J. A., Harvey, J. M., Nathanson, L., Barnes, Z. M., Klimas, N. G., FLETCHER, M. A., & Broderick, G. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0111-3 · Cited by 30
A look into the future of ALS research
Clerc, P., Lipnick, S., & Willett, C. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.02.002 · Cited by 30
Amyotrophic lateral sclerosis mimic syndromes.
Ghasemi, M. (2016) · Europe PMC (PubMed Central) · Cited by 30
Marino, C., Grimaldi, M., Sommella, E., Ciaglia, T., Santoro, A., Buonocore, M., Salviati, E., Trojsi, F., Polverino, A., Sorrentino, P., et al. (2022) · Metabolites · doi:10.3390/metabo12090837 · Cited by 31
Female gender doubles executive dysfunction risk in ALS: a case-control study in 165 patients
Palmieri, A., Mento, G., Calvo, V., Querin, G., D’Ascenzo, C., Volpato, C., Kleinbub, J. R., Bisiacchi, P. S., & Sorarú, G. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-307654 · Cited by 30
Copper toxicity and deficiency: the vicious cycle at the core of protein aggregation in ALS
Min, J.-H., Sarlus, H., & Harris, R. A. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1408159 · Cited by 31
Ovsepian, S. V., O’Leary, V. B., & Martı́nez, S. (2023) · Brain Structure and Function · doi:10.1007/s00429-023-02728-6 · Cited by 30
Perera, N. D., Sheean, R. K., Crouch, P. J., White, A. R., Horne, M. K., & Turner, B. J. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw247 · Cited by 28
Cortés, C. J., & Miguel, Z. D. (2022) · Brain Plasticity · doi:10.3233/bpl-220139 · Cited by 34
Recent Advances in Extracellular Vesicles in Amyotrophic Lateral Sclerosis and Emergent Perspectives
Afonso, G. J. M., Cavaleiro, C., Valero, J., Mota, S. I., & Ferreiro, E. B. (2023) · Cells · doi:10.3390/cells12131763 · Cited by 28
Tongue muscle contractile, fatigue, and fiber type properties in rats
Fogarty, M. J., & Sieck, G. C. (2021) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00329.2021 · Cited by 27
Wang, G., Zhou, X., Pang, X., Ma, K., Li, L., Song, Y., Hou, D., & Wang, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1625821 · Cited by 28
Agah, E., Saleh, F., Moghaddam, H. S., Saghazadeh, A., Tafakhori, A., & Rezaei, N. (2018) · Systematic Reviews · doi:10.1186/s13643-018-0913-4 · Cited by 26
Telomere length is greater in ALS than in controls: a whole genome sequencing study
Khleifat, A. A., Iacoangeli, A., Shatunov, A., Fang, T., Sproviero, W., Jones, A. R., Opie-Martin, S., Morrison, K. E., Shaw, P. J., Shaw, C. E., et al. (2019) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2019.1586951 · Cited by 26
Amyotrophic Lateral Sclerosis: Drug Therapy from the Bench to the Bedside
Bromberg, M. B., & Gibson, S. B. (2012) · Seminars in Neurology · doi:10.1055/s-0032-1329193 · Cited by 26
Kreilaus, F., Guerra, S., Masanetz, R. K., Menne, V., Yerbury, J. J., & Karl, T. (2019) · Genes Brain & Behavior · doi:10.1111/gbb.12604 · Cited by 24
Neuronal–glial communication perturbations in murine SOD1G93A spinal cord
MacLean, M., López‐Díez, R., Vásquez, C., Gugger, P. F., & Schmidt, A. M. (2022) · Communications Biology · doi:10.1038/s42003-022-03128-y · Cited by 25
Tavazzi, E., Daberdaku, S., Zandonà, A., Vasta, R., Nefussy, B., Lunetta, C., Mora, G., Mandrioli, J., Grisan, E., Tarlarini, C., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11022-0 · Cited by 26
Hayes-Punzo, A., Mulcrone, P. L., Meyer, M., McHugh, J., Svendsen, C. N., & Suzuki, M. (2012) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2012.654393 · Cited by 25
Cuffaro, F., Lamminpää, I., Niccolai, E., & Amedei, A. (2024) · Nutrients · doi:10.3390/nu17010102 · Cited by 25
Brain–body mechanisms contribute to sexual dimorphism in amyotrophic lateral sclerosis
Jacob, S. M., Lee, S., Kim, S. H., Sharkey, K. A., Pfeffer, G., & Nguyen, M. D. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00991-7 · Cited by 25
Drigo, D., Verriello, L., Clagnan, E., Eleopra, R., Pizzolato, G., Bratina, A., D'Amico, D., Sartori, A., Masè, G., Simonetto, M., et al. (2013) · Neuroepidemiology · doi:10.1159/000350015 · Cited by 24
Tai, H., Cui, L., Liu, M., Guan, Y., Li, X., Shen, D., Zhang, K., Liu, S., Wu, S., Ding, Q., et al. (2018) · Clinical Neurophysiology · doi:10.1016/j.clinph.2018.01.071 · Cited by 24
Santiago, J. A., Quinn, J. P., & Potashkin, J. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137150 · Cited by 21
Korhonen, P., Pollari, E., Kanninen, K. M., Savchenko, E., Lehtonen, Š., Wojciechowski, S., Pomeshchik, Y., Bosch, L. V. D., Goldsteins, G., Koıstınaho, J., et al. (2019) · IBRO Reports · doi:10.1016/j.ibror.2019.01.005 · Cited by 24
Marques, R. F., Engler, J. B., Küchler, K., Jones, R. A., Lingner, T., Salinas, G., Gillingwater, T. H., Friese, M. A., & Duncan, K. E. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa140 · Cited by 24
Dukkipati, S. S., Chihi, A., Wang, Y., & Elbasiouny, S. M. (2017) · eNeuro · doi:10.1523/eneuro.0281-16.2016 · Cited by 23
From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis
Alrafiah, A. (2018) · In Vivo · doi:10.21873/invivo.11339 · Cited by 28
Sexual Dimorphism in Neurodegenerative Diseases and in Brain Ischemia
Zalewska, T., Pawelec, P., Ziąbska, K., & Ziemka‐Nałęcz, M. (2022) · Biomolecules · doi:10.3390/biom13010026 · Cited by 23
A Review of Biomarkers of Amyotrophic Lateral Sclerosis: A Pathophysiologic Approach
Alshehri, R. S., Abuzinadah, A. R., Alrawaili, M. S., Alotaibi, M. K., Alsufyani, H. A., Alshanketi, R. M., & Alshareef, A. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010900 · Cited by 23
Amino Acids as biomarkers in the SOD1G93A mouse model of ALS
Bame, M., Grier, R. E., Needleman, R. B., & Brusilow, W. S. A. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.10.004 · Cited by 20
Sex-Specific Differences in Motor-Unit Remodeling in a Mouse Model of ALS
Martineau, É., Polo, A. D., Velde, C. V., & Robitaille, R. (2020) · eNeuro · doi:10.1523/eneuro.0388-19.2020 · Cited by 21
Pridopidine modifies disease phenotype in a SOD1 mouse model of amyotrophic lateral sclerosis
Estévez-Silva, H. M., Mediavilla, T., Giacobbo, B. L., Liu, X., Sultan, F. R., & Marcellino, D. J. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15608 · Cited by 21
Impact of Pharmacological Inhibition of Hydrogen Sulphide Production in the SOD1G93A-ALS Mouse Model
Spalloni, A., Greco, V., Ciriminna, G., Carregari, V. C., Marini, F., Pieroni, L., Mercuri, N. B., Urbani, A., & Longone, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102550 · Cited by 22
Prostaglandins in the Inflamed Central Nervous System: Potential Therapeutic Targets
Noakes, P., Sheremeta, C.-L., Yarlagadda, S., & Smythe, M. L. (2024) · Current Drug Targets · doi:10.2174/0113894501323980240815113851 · Cited by 20
McLeod, V. M., Chiam, M. D. F., Lau, C. L., Rupasinghe, T., Boon, W. C., & Turner, B. J. (2020) · Endocrinology · doi:10.1210/endocr/bqaa113 · Cited by 19
Fávero, F. M., Voos, M. C., de Castro, I., Caromano, F. A., & Oliveira, A. S. B. (2017) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20170083 · Cited by 20
Late age onset of amyotrophic lateral sclerosis is often not considered in elderly people
Broussalis, E., Grinzinger, S., Kunz, A. B., Killer‐Oberpfalzer, M., Haschke‐Becher, E., Hartung, H., & Kraus, J. (2017) · Acta Neurologica Scandinavica · doi:10.1111/ane.12869 · Cited by 20
Daniela Gerovska, D., Irizar, H., Otaegi, D., Ferrer, I., de Munaín, A. L., & Araúzo-Bravo, M. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-75014-8 · Cited by 22
Human cerebral evolution and the clinical syndrome of amyotrophic lateral sclerosis
Henderson, R. D., Garton, F. C., Kiernan, M. C., Turner, M. R., & Eisen, A. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-317245 · Cited by 20
Neuroprotective Effects of Estradiol on Motoneurons in a Model of Rat Spinal Cord Embryonic Explants
Cardona-Rossinyol, A., Mir, M., Caraballo-Miralles, V., Lladó, J., & Olmos, G. (2013) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-013-9908-9 · Cited by 24
Assessment of ALS mortality in a cohort of formaldehyde-exposed garment workers
Pinkerton, L. E., Hein, M. J., Meyers, A. R., & Kamel, F. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.778284 · Cited by 19
Clinical features of amyotrophic lateral sclerosis in south-west China
Wei, Q., Chen, X., Zheng, Z., Huang, R., Guo, X., Cao, B., Zhao, B., & Shang, H. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1069849 · Cited by 19
Motoneuron excitability dysfunction in ALS: Pseudo‐mystery or authentic conundrum?
Elbasiouny, S. M. (2022) · The Journal of Physiology · doi:10.1113/jp283630 · Cited by 17
Fungal-contaminated grass and well water and sporadic amyotrophic lateral sclerosis
French, P. W., Ludowyke, R. I., & Guillemin, G. J. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.255959 · Cited by 18
Nayak, N., & Mishra, M. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2102066 · Cited by 19
Use of Bayesian MUNE to show differing rate of loss of motor units in subgroups of ALS
Baumann, F., Henderson, R. D., Ridall, G., Pettitt, A. N., & McCombe, P. (2012) · Clinical Neurophysiology · doi:10.1016/j.clinph.2012.04.022 · Cited by 18
Xiao, W. L., Zhao, L., Wang, F., Sun, H., Wang, T., & Zhao, G. (2016) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2016.10.009 · Cited by 18
Raffaele, S., Nguyen, N., Milanese, M., Mannella, F. C., Boccazzi, M., Frumento, G., Bonanno, G., Abbracchio, M. P., Bonifacino, T., & Fumagalli, M. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16408 · Cited by 18
Kim, S. H., Shishido, Y., Sogabe, H., Rachadech, W., Yorita, K., Kato, Y., & Fukui, K. (2019) · The Journal of Biochemistry · doi:10.1093/jb/mvz025 · Cited by 17
Female sex mitigates motor and behavioural phenotypes in TDP-43Q331K knock-in mice
Watkins, J., Ghosh, A., Keerie, A. F. A., Alix, J. J. P., Mead, R. J., & Sreedharan, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-76070-w · Cited by 17
Key Disease Mechanisms Linked to Amyotrophic Lateral Sclerosis in Spinal Cord Motor Neurons
Bottero, V., Santiago, J. A., Quinn, J. P., & Potashkin, J. A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.825031 · Cited by 17
Gargiulo-Monachelli, G. M., Meyer, M., Lara, A., Garay, L. I., Lima, A. E., Roig, P., Nicola, A. F. D., & Deniselle, M. C. G. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105385 · Cited by 18
Bak, A. N., Djukic, S., Kadlecová, M., Braunstein, T. H., Jensen, D. B., & Meehan, C. F. (2023) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2023.103840 · Cited by 13
Immunological Aspects in Amyotrophic Lateral Sclerosis
Oliveira, M. C., Voltarelli, J. C., Sanberg, P. R., Borlongan, C. V., & Garbuzova-Davis, S. N. (2012) · Translational Stroke Research · doi:10.1007/s12975-012-0177-6 · Cited by 16
Soliman, R., Mousa, N. O., Rashed, H. R., Moustafa, R. R., Hamdi, N., Osman, A., & Fahmy, N. A. (2021) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2021.106883 · Cited by 16
Shoenfeld, L. R., Westenbroek, R. E., Fisher, E., Quinlan, K. A., Tysseling, V. M., Powers, R. K., Heckman, C. J., & Binder, M. D. (2014) · Physiological Reports · doi:10.14814/phy2.12113 · Cited by 16
Kullmann, J. A. P., Hayes, S. C., & Pamphlett, R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204424 · Cited by 16
Andrew, A. S., Zhou, J., Gui, J., Harrison, A., Shi, X., Li, M., Guetti, B., Nathan, R., Tischbein, M., Pioro, E. P., et al. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.153096 · Cited by 20
Mazumder, S., Kiernan, M. C., Halliday, G. M., Timmins, H. C., & Mahoney, C. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12845 · Cited by 14
Sheean, R. K., Weston, R. H., Perera, N. D., D’Amico, A., Nutt, S. L., & Turner, B. J. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0254-3 · Cited by 15
Yuan, X., Cao, B., Wu, Y., Chen, Y., Wei, Q., Ou, R., Yang, J., Chen, X.-P., Zhao, B., Song, W., et al. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.11.015 · Cited by 16
Linking Puberty and the Gut Microbiome to the Pathogenesis of Neurodegenerative Disorders
Esposito, P., & Ismail, N. (2022) · Microorganisms · doi:10.3390/microorganisms10112163 · Cited by 14
Brunialti, E., Villa, A. M., Toffoli, M., Pozo, S. L. D., Rizzi, N., Meda, C., Maggi, A. C., Schapira, A. H. V., & Ciana, P. (2023) · Cells · doi:10.3390/cells12030343 · Cited by 14
Moloney, E. B., Hobo, B., de Winter, F., & Verhaagen, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170314 · Cited by 14
Schäfer, S., & Hermans, E. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.06.019 · Cited by 14
Sazcı, A., Ozel, M. D., Emel, E., & Idrısoğlu, H. A. (2012) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2011.0313 · Cited by 14
Expression of aromatase and estrogen receptors in lumbar motoneurons of mice
Ji, Y., Zhao, M., Liu, Y., Chen, L.-S., Hao, P., & Sun, C. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.05.017 · Cited by 14
Barros, J. B. D. S., Santos, K. D. F., Azevedo, R. M., de Oliveira, R. P. D., Leobas, A. C. D., Bento, D. D. C. P., Santos, R. D. S., & Reis, Â. A. D. S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247024 · Cited by 14
The incidence and prevalence of motor neurone disease in South Australia
Luker, J., Woodman, R. J., & Schultz, D. W. (2022) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2022.2108326 · Cited by 13
ALS risk factors: Industrial airborne chemical releases
Andrew, A. S., Zhou, J., Gui, J., Shi, X., Li, M., Harrison, A., Guetti, B., Nathan, R., Butt, T. H., Peipert, D., et al. (2021) · Environmental Pollution · doi:10.1016/j.envpol.2021.118658 · Cited by 14
Quality of life, disability, and clinical variables in amyotrophic lateral sclerosis
Alencar, M. A., da Silva, I. M. M., Hilário, S. M., Rangel, M. F. D. A., Abdo, J. S., de Araújo, C. M., & de Souza, L. C. (2021) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x-anp-2021-0201 · Cited by 13
Age-dependent increase of cytoskeletal components in sensory axons in human skin
Metzner, K., Darawsha, O., Wang, M., Gaur, N., Cheng, Y., Rödiger, A., Frahm, C., Witte, O. W., Perocchi, F., Axer, H., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.965382 · Cited by 12
Maksymowicz-Śliwińska, A., Lulé, D. E., Nieporęcki, K., Ciećwierska, K., Ludolph, A. C., & Kuźma‐Kozakiewicz, M. (2022) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2022.2126322 · Cited by 13
Highlander, M. M., & Elbasiouny, S. M. (2022) · Bioengineering · doi:10.3390/bioengineering9090441 · Cited by 12
Mutant and curli-producing E. coli enhance the disease phenotype in a hSOD1-G93A mouse model of ALS
Kurlawala, Z., McMillan, J. D., Singhal, R. A., Morehouse, J. R., Burke, D. A., Sears, S. M., Duregon, E., Beverly, L. J., Siskind, L. J., & Friedland, R. P. (2023) · Scientific Reports · doi:10.1038/s41598-023-32594-5 · Cited by 12
Effects of sex, mating status, and genetic background on circadian behavior in Drosophila
Akpoghiran, O., Strich, A. K., & Koh, K. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1532868 · Cited by 13
Deciphering hypothalamic pathology in ALS: insights into non-motor symptoms and disease progression
Chang, J., Teo, A. H., Shaw, T. B., Dupuis, L., Ngo, S. T., & Steyn, F. J. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105845 · Cited by 12
Yang, X., Zhao, Q., An, R., Zheng, J., Tian, S., & Xu, Y. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1054291 · Cited by 12
Metadata
- Authors
- McCombe, P. A., & Henderson, R. D.
- Affiliations
- The University of Queensland (AU)
- Corresponding author
- McCombe, Pamela A.
- Venue
- Gender Medicine
- Publisher
- Elsevier BV
- Published
- 2010-12
- Volume
- 7
- Issue
- 6
- Pages
- 557-570
- ISSN
- 1550-8579 (ISSN-L)
- OpenAlex
- W2007336957
- Cited by
- 379
- References
- 122
- Citations by year
- 2026: 26 · 2025: 23 · 2024: 32 · 2023: 25 · 2022: 41 · 2021: 36 · 2020: 28 · 2019: 27 · 2018: 18 · 2017: 30 · 2016: 24 · 2015: 13 · 2014: 13 · 2013: 18 · 2012: 19
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gender Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Sanofi
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Keywords
- amyotrophic lateral sclerosis, motor neuron disease, sex differences, clinical phenotype, familial ALS, sporadic ALS, survival, environmental toxin exposure
- MeSH terms
- Amyotrophic Lateral Sclerosis, Animals, Environmental Exposure, Female, Humans, Male, Nervous System Physiological Phenomena, Sex Factors, Incidence, Prevalence, Age of Onset, Models, Animal, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review